Special Article
Free Access
Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease
Michael Houghton Ph.D.,
Amy Weiner, Jang Han, George Kuo, Qui-Lim Choo,
Corresponding Author
Michael Houghton Ph.D.
Chiron Corporation, Emeryville, California 94608
Director, NANB Hepatitis Research, Chiron Corp., Emeryville, CA 94608===Search for more papers by this authorMichael Houghton Ph.D.,
Amy Weiner, Jang Han, George Kuo, Qui-Lim Choo,
Corresponding Author
Michael Houghton Ph.D.
Chiron Corporation, Emeryville, California 94608
Director, NANB Hepatitis Research, Chiron Corp., Emeryville, CA 94608===Search for more papers by this author
References
- 1 Choo Q-L, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359–362.
- 2 Kuo G, Choo Q-L, Alter HJ, Gitnick GI, Redeker AG, Purcell RH, Miyamura T, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 1989; 244: 362–364.
- 3 Van der Poel CL, Reesink HW, Lelie PN, Leentvaar-Kuypers A, Choo Q-L, Kuo G, Houghton M. Anti-hepatitis C antibodies and non-A, non-B post-transfusion hepatitis in the Netherlands. Lancet 1989; 2: 297–298.
- 4 Esteban JI, Esteban R, Viladomiu L, López-Talavera JC, González A, Hernández JM, Roget M, et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294–297.
- 5 Alter HJ, Purcell RH, Shih JW, Melpolder JC, Houghton M, Choo Q-L, Kuo G. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis. New Eng J Med 1989; 321: 1494–1500.
- 6 Miyamura T, Saito I, Katayama T, Kikuchi S, Tateda A, Houghton M, Choo Q-L, et al. Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis. Proc Natl Acad Sci USA 1990; 87: 983–987.
- 7 Choo Q-L, Weiner AJ, Overby LR, Kuo G, Houghton M, Bradley DW. Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis. Br Med Bull 1990; 46: 423–441.
- 8 Alter M, Hadler SC, Judson FN, Mares A, Alexander WJ, Hu PY, Miller JK, et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA 1990; 264: 2231–2235.
- 9 Hopf U, Möller B, Küther D, Stemerowicz R, Lobeck H, Lüdtke-Handjery A, Walter E, et al. Long-term follow-up of posttransfusion and sporadic chronic hepatitis non-A, non-B and frequency of circulating antibodies to hepatitis C virus (HCV). J Hepatol 1990; 10: 69–76.
- 10 Colombo M, Kuo G, Choo Q-L, Donato MF, Del Ninno E, Tommasini MA, Dioguardi N, et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989; 2: 1006–1008.
- 11 Sansonno D, Dammacco F. Antibodies to hepatitis C virus in non-A, non-B post-transfusion and cryptogenetic chronic liver disease. Lancet 1989; 2: 798–799.
- 12 Saito I, Miyamura T, Ohbayashi A, Harada H, Katayama T, Kikuchi S, Watanabe Y, et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547–6549.
- 13
Nishioka K,
Watanabe J,
Furuta S,
Tanaka E,
Iino S,
Suzuki H,
Tsuji T, et al.
A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan.
Cancer
1991;
67:
429–433.
10.1002/1097-0142(19910115)67:2<429::AID-CNCR2820670218>3.0.CO;2-# CAS PubMed Web of Science® Google Scholar
- 14 Bruix J, Barrera JM, Calvet X, Ercilla G, Costa J, Sanchez-Tapias JM, Ventura M, et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989; 2: 1004–1006.
- 15 Choo Q-L, Richman KH, Han JH, Berger K, Lee C, Dong C, Gallegos C, et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451–2455.
- 16 Kato N, Hijikata M, Ootsuyama Y, Nakagawa M, Ohkoshi S, Sugimura T, Shimotohno K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc Natl Acad Sci USA 1990; 87: 9524–9528.
- 17 Takamizawa A, Mori C, Fuke I, Manabe S, Murakami S, Fujita J, Onishi E, et al. Structure and organization of the hepatitis C virus genome isolated from human carriers. J Virol 1991; 65: 1105–1113.
- 18 Okamoto H, Okada S, Sugiyama Y, Yotsumoto S, Tanaka T, Yoshizawa H, Tsuda F, et al. The 5′-terminal sequence of the hepatitis C virus genome. Jpn J Exp Med 1991; 60: 167–177.
- 19 Han JH, Shyamala V, Richman KH, Brauer MJ, Irvine B, Urdea MS, Tekamp-Olson P, et al. Characterization of the terminal regions of hepatitis C viral RNA: identification of conserved sequences in the 5′ untranslated region and poly(A) tails at the 3′ end. Proc Natl Acad Sci USA 1991; 88: 1711–1715.
- 20 Collett MS, Anderson DK, Retzel E. Comparisons of the pestivirus bovine viral diarrhoea virus with members of the Flaviviridae. J Gen Virol 1988; 69: 2637–2643.
- 21 Houghton M, Choo Q-L, Kuo G. European Patent Application 88,310,922.5; Publication 318.216.
- 22 Choo Q-L, Han J, Weiner AJ, Overby LR, Bradley DW, Kuo G, Houghton M. Hepatitis C virus is a distant relative of the flaviviruses and pestiviruses. In: T Shikata, RH Purcell, T Uchida, eds. Proceedings of the 1989 International Symposium on Viral Hepatitis C, D and E. Amsterdam: Elsevier Science Publishers, 1991; 47–52.
- 23 Miller RH, Purcell RH. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups. Proc Natl Acad Sci USA 1990; 87: 2057–2061.
- 24 Takeuchi K, Kubo Y, Boonmar S, Watanabe Y, Katayama T, Choo Q-L, Kuo G, et al. The putative nucleocapsid and envelope protein genes of hepatitis C virus determined by comparison of the nucleotide sequences of two isolates derived from an experimentally infected chimpanzee and healthy human carriers. J Gen Virol 1990; 71: 3027–3033.
- 25 Bradley DW. The agents of non-A, non-B hepatitis. J Virol Methods 1985; 10: 307–319.
- 26 He L-F, Alling D, Popkin T, Shapiro M, Alter HJ, Purcell RH. Determining the size of non-A, non-B hepatitis virus by filtration. J Infect Dis 1987; 156: 636–640.
- 27 Collett MS, Moennig V, Horzinek MC. Recent advances in pestivirus research. J Gen Virol 1989; 70: 253–266.
- 28 Weiland E, Stark R, Haas B, Rümenapf T, Meyers G, Thiel HJ. Pestivirus glycoprotein which induces neutralizing antibodies forms part of a disulfide-linked heterodimer. J Virol 1990; 64: 3563–3569.
- 29
Rice CM,
Strauss EG,
Strauss JH.
Structure of the flavivirus genome. In:
S Schlesinger,
MJ Schlesinger, eds.
Togaviridae and Flaviviridae.
New York:
Plenum Press,
1986;
279–326.
10.1007/978-1-4757-0785-4_10 Google Scholar
- 30 Chambers TJ, Weir RC, Grakoui A, McCourt DW, Bazan JF, Fletterick RJ, Rice CM. Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein. Proc Natl Acad Sci USA 1990; 87: 8898–8902.
- 31 Chambers TJ, McCourt DW, Rice CM. Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using regionspecific polyclonal antisera. Virology 1990; 177: 159–174.
- 32 Kubo Y, Takeuchi K, Boonmar S, Katayama T, Choo Q-L, Kuo G, Weiner AJ, et al. A cDNA fragment of hepatitis C virus isolated from an implicated donor of post-transfusion non-A, non-B hepatitis in Japan. Nucleic Acids Res 1989; 17: 10367–10372.
- 33 Takeuchi K, Boonmar S, Kubo Y, Katayama T, Harada H, Ohbayashi A, Choo Q-L, et al. Hepatitis C viral cDNA clones isolated from a healthy carrier donor implicated in posttransfusion non-A, non-B hepatitis. Gene 1990; 91: 287–291.
- 34 Takeuchi K, Kubo Y, Boonmar S, Watanabe Y, Katayama T, Choo Q-L, Kuo G, et al. Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers. Nucleic Acids Res 1990; 18: 4626.
- 35 Kato N, Ohkoshi S, Shimotohno K. Japanese isolates of the non-A, non-B hepatitis viral genome show sequence variations from the original isolate in the USA. Proc Jpn Acad 1989; 65B: 219–223.
- 36 Maeno M, Kaminaka K, Sugimoto H, Esumi M, Hayashi N, Komatsu K, Abe K, et al. A cDNA clone closely associated with non-A, non-B hepatitis. Nucleic Acids Res 1990; 18: 2685–2689.
- 37 Weiner AJ, Brauer MJ, Rosenblatt J, Richman KH, Tung J, Crawford K, Bonino F, et al. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 1991; 180 – 842–848.
- 38 Putney SD, Vasios CM. AIDS vaccines development: current research and patent considerations. In: Current antimicrobial patents. Vol 2. UK: 543–556.
- 39 Tsukiyama-Kohara K, Kohara M, Yamaguchi K, Maki N, Toyoshima A, Miki K, Tanaka S, et al. A second group of hepatitis C virus. Virus Genes; in press.
- 40 Enomoto N, Takada A, Nakao T, Date T. There are two major types of hepatitis C virus in Japan. Biochem Biophys Res Commun 1990; 170: 1021–1025.
- 41 Simmonds P, Zhang L-Q, Watson HG, Rebus S, Ferguson ED, Balfe P, Leadbetter GH, et al. Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users. Lancet 1990; 336: 1469–1472.
- 42 Esteban JI, González A, Hernández JM, Viladomiu L, Sánchez C, López-Talavera JC, Lucea D, et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990; 323: 1107–1112.
- 43 Tanaka E, Kiyosawa K, Sodeyama T, Nakano Y, Yoshizawa K, Hayata T, Shimizu S, et al. Significance of antibody to hepatitis C virus in Japanese patient with viral hepatitis: relationship between anti-HCV antibody and the prognosis of non-A, non-B post-transfusion hepatitis. J Med Virol 1991; 33: 117–122.
- 44 Weiner AJ, Kuo G, Bradley DW, Bonino F, Saracco G, Lee C, Rosenblatt J, et al. Detection of hepatitis C viral sequences in non-A, non-B hepatitis. Lancet 1990; 335: 1–3.
- 45 Katayama T, Kikuchi S, Tanaka Y, Saito I, Miyamura T, Choo Q-L, Houghton M, et al. Blood screening for non-A, non-B hepatitis by hepatitis C virus antibody assay. Transfusion 1990; 30: 374–376.
- 46 Kuo G, Choo Q-L, Shuster J, Kuo C, Berger K, Lee WS, Medina-Selby A, et al. The serodiagnosis of hepatitis C viral infection using recombinant-based assays for circulating antibodies to different viral proteins. In: FB Hollinger, SM Lemon, HS Margolis, eds. Proceedings of 1990 International Symposium on Viral Hepatitis. Baltimore: Williams & Wilkins: In press.
- 47 Choo Q-L, Berger K, Kuo G, Houghton M. The detection and mapping of immunological epitopes expressed by bacterial cDNA clones of the hepatitis C virus. In: FB Hollinger, SM Lemon, HS Margolis, eds. Proceedings of 1990 International Symposium on Viral Hepatitis. Baltimore: Williams & Wilkins: In press.
- 48 Kuo G. Serodiagnosis of hepatitis C virus infection: the immune response to multiple viral antigens. In: Proceedings of the 2nd International Symposium on HCV. NJ: Advanced Therapeutic Communications, 1991.
- 49 Van der Poel CL, Cuypers HTM, Reesink HW, Weiner AJ, Quan S, Di Nello R, Van Boven JJP, et al. Confirmation of hepatitis C virus infection by new four-antigen recombinant immunoblot assay. Lancet 1991; 337: 317–319.
- 50 Shimizu YK, Weiner AJ, Rosenblatt J, Wong DC, Shapiro M, Popkin T, Houghton M, et al. Early events in hepatitis C virus infection of chimpanzees. Proc Natl Acad Sci USA 1990; 87: 6441–6444.
- 51 Garson JA, Tuke PW, Makris M, Briggs M, Machin SJ, Preston FE, Tedder RS. Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus contaminated factor VIII concentrates. Lancet 1990; 336: 1022–1025.
- 52 Garson JA, Ring C, Tuke P, Tedder RS. Enhanced detection by PCR of hepatitis C virus RNA. Lancet 1990; 336: 878–879.
- 53 Kanai K, Iwata K, Nakao K, Kako M, Okamoto H. Suppression of hepatitis C virus RNA by interferon-α. Lancet 1990; 336: 245.
- 54 Weiner AJ, Truett MA, Rosenblatt J, Han J, Quan S, Polito AJ, Kuo G, et al. HCV testing in low-risk population. Lancet 1990; 336: 695.
- 55 Thaler MM, Park C-K, Landers DV, Wara DW, Houghton M, Veereman-Wauters G, Sweet RL, et al. Vertical transmission of hepatitis C virus. Lancet; in press.
- 56
Porterfield JS.
Comparative and historical aspects of the togaviridae and flaviviridae. In:
S Schlesinger,
MJ Schlesinger, eds.
The Togaviridae and Flaviviridae
New York:
Plenum Press,
1986:
1–19.
10.1007/978-1-4757-0785-4_1 Google Scholar
- 57 Payne SL, Salinovich O, Nauman SM, Issel CI, Montelaro RC. Course and extent of variation of equine infectious anemia virus during parallel persistent infections. J Virol 1987; 61: 1266–1270.
- 58 Meyers G, Tautz N, Dubovi EJ, Thiel HJ. Viral cytopathogenicity correlated with integration of ubiquitin-coding sequences. Virology 1991; 180: 602–616.
- 59 Dienstag JL, Alter HJ. Non-A, non-B hepatitis: evolving epidemiologic and clinical perspective. Semin Liver Dis 1986; 6: 67–81.
- 60 Halstead SB, Venkateshan CN, Gentry MK, Larsen LK. Heterogeneity of infection enhancement of dengue 2 strains by monoclonal antibodies. J Immunol 1984; 132: 1529–1532.
- 61 Rümenapf T, Stark R, Meyers G, Thiel H-J. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J Virol 1991; 65: 589–597.
- 62 Zhang Y-M, Hayes EP, McCarty TC, Dubois DR, Summers PL, Eckels KH, Chanock RM, et al. Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis. J Virol 1988; 62: 3027–3031.
- 63 Stephenson JR. Flavivirus vaccines. Vaccine 1988; 6: 471–480.
- 64 Nomenclature and symbolism for amino acids and peptides: recommendations 1983. J Biol Chem 1985; 260: 14–42.
